Genetics of rheumatoid arthritis
- PMID: 35088123
- PMCID: PMC8837504
- DOI: 10.1007/s00281-022-00912-0
Genetics of rheumatoid arthritis
Abstract
Rheumatoid arthritis (RA) is an inflammatory autoimmune disease involving symmetric joints and is generally characterized by persistent pain, tenderness, and destruction of joints. The vast majority of RA patients produce autoantibodies, and immune cell involvement in disease development is well recognized, as is the contribution of other types of cells in synovial tissue, like fibroblasts. It is known that there are major genetic associations with the HLA locus, while multiple non-HLA genetic variants display relatively low risk of RA. Both HLA and non-HLA associations suggest that the profiles of genetic associations for autoantibody-positive vs. autoantibody-negative RA are different. Several alleles of HLA-DRB1 are associated with high risk for autoantibody-positive RA, with the strongest risk characterized by valine at position 11 of the protein sequence (HLA-DRB1*04 and *10 alleles). There is a strong protective effect for the risk of autoantibody-positive RA associated with HLA-DRB1*13 alleles. Although major genetic associations have been known for several years, understanding of the specific mechanisms in the development of increased risk of RA for these variations is work in progress. Current studies focus on the binding of immune receptors involved in recognition of putative peptides in activation of T cells, as well as investigation of cell signaling mechanisms. At least a part of RA risk could be explained by gene-gene and gene-environment interactions. There are currently more than 150 candidate loci with polymorphisms that associate with RA, mainly related to seropositive disease, and new discoveries are anticipated in the future from investigation of diverse human populations. This new research will help create a strong foundation for the continuing process of integrating genetic, epigenetic, transcriptomic, and proteomic data in studies of RA.
Keywords: Autoantibody; Autoimmunity; Genetic polymorphism; HLA; Inflammation; Rheumatoid arthritis.
© 2022. The Author(s).
Conflict of interest statement
The author declares no competing interests.
Figures
Similar articles
-
HLA class II alleles influence rheumatoid arthritis susceptibility and autoantibody status in South Indian Tamil population.HLA. 2016 Nov;88(5):253-258. doi: 10.1111/tan.12910. HLA. 2016. PMID: 27753285
-
HLA-C alleles confer risk for anti-citrullinated peptide antibody-positive rheumatoid arthritis independent of HLA-DRB1 alleles.Rheumatology (Oxford). 2013 Nov;52(11):1973-82. doi: 10.1093/rheumatology/ket252. Epub 2013 Jul 30. Rheumatology (Oxford). 2013. PMID: 23901134
-
Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis.Arthritis Res Ther. 2014 Aug 20;16(4):414. doi: 10.1186/s13075-014-0414-3. Arthritis Res Ther. 2014. PMID: 25138370 Free PMC article.
-
The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review.Cells. 2020 Feb 19;9(2):475. doi: 10.3390/cells9020475. Cells. 2020. PMID: 32092988 Free PMC article. Review.
-
Recent Advances in Defining the Genetic Basis of Rheumatoid Arthritis.Annu Rev Genomics Hum Genet. 2016 Aug 31;17:273-301. doi: 10.1146/annurev-genom-090314-045919. Epub 2016 May 23. Annu Rev Genomics Hum Genet. 2016. PMID: 27216775 Free PMC article. Review.
Cited by
-
Development of biomedical hydrogels for rheumatoid arthritis treatment.Asian J Pharm Sci. 2024 Feb;19(1):100887. doi: 10.1016/j.ajps.2024.100887. Epub 2024 Feb 5. Asian J Pharm Sci. 2024. PMID: 38419762 Free PMC article. Review.
-
STAT4 Gene Variant rs7574865 Is Associated with Rheumatoid Arthritis Activity and Anti-CCP Levels in the Western but Not in the Southern Population of Mexico.Genes (Basel). 2024 Feb 14;15(2):241. doi: 10.3390/genes15020241. Genes (Basel). 2024. PMID: 38397230 Free PMC article.
-
Triterpenes Drug Delivery Systems, a Modern Approach for Arthritis Targeted Therapy.Pharmaceuticals (Basel). 2023 Dec 28;17(1):54. doi: 10.3390/ph17010054. Pharmaceuticals (Basel). 2023. PMID: 38256888 Free PMC article. Review.
-
Exploring the mechanism of Celastrol in the treatment of rheumatoid arthritis based on systems pharmacology and multi-omics.Sci Rep. 2024 Jan 18;14(1):1604. doi: 10.1038/s41598-023-48248-5. Sci Rep. 2024. PMID: 38238321 Free PMC article.
-
Computational 3D Modeling-Based Identification of Inhibitors Targeting Cysteine Covalent Bond Catalysts for JAK3 and CYP3A4 Enzymes in the Treatment of Rheumatoid Arthritis.Molecules. 2023 Dec 19;29(1):23. doi: 10.3390/molecules29010023. Molecules. 2023. PMID: 38202604 Free PMC article.
References
-
- Almutairi KB, et al. The prevalence of rheumatoid arthritis: a systematic review of population-based studies. J Rheumatol. 2021;48(5):669–676. - PubMed
-
- McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205–2219. - PubMed
-
- Catrina AI, et al. Mechanisms involved in triggering rheumatoid arthritis. Immunol Rev. 2016;269(1):162–174. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
